Traumatic Brain Injury

Houston Methodist

M. E. Zwillman

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

RheumNow

J. Cush

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Safety and Monitoring Considerations in Systematic Therapy

Masterclasses in Dermatology

J. Cohen

Imaging Considerations for the Dermatologist

Masterclasses in Dermatology

C. Bakewell

Points to Consider When Managing Inflammatory Arthritis with Cancer

RheumNow

J. Cush

AAD 2024 Insights: Prevention and Active Surveillance of Keratinocyt…

Brigham and Women's Hospital Department of Dermatology

R. Hartman

Summer AAD 2024 Insights: Advances in Merkel Cell Carcinoma- Using C…

AAD 2024

L. Zaba

EASD Insights: Long-term Complications in Diabetes - From Classical …

Stephan Herzig

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…

2024 Clinical Case Studies

J. Murase

USSONAR Rheumatology Ultrasound Case Series: A Case of Dactylitis in…

USSONAR

J. Medlin

We Never Looked: What Happens When Gynecologic Care Ceases After Age…

Amaris Geisler

Experts Discuss Key Updates in CLL

ASH 2022 Conference Coverage

S. O'Brien, C. Coombs

Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…

Alan Skarbnik

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

Diagnosis and Management of Rare Skin Cancers: What Every Dermatolog…

Nour Kibbi

ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for…

ecancer

J. Brown

Zanubrutinib for the Treatment of CLL: Learnings From ALPINE, SEQUOI…

Seema Bhat

Challenging Case: A Patient with Comorbid Solid Organ Malignancy

International Psoriasis Council (IPC)

M. Angeliki Gkini